This HTML5 document contains 133 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n13http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n7https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q48565555
rdf:type
wikibase:Item
schema:description
scientific article published on 20 October 2011 επιστημονικό άρθρο tieteellinen artikkeli 2011年学术文章 articol științific artículo científico publicado en 2011 مقالة علمية نشرت في 20 أكتوبر 2011 artikel ilmiah 2011년 논문 artículu científicu artigo científico 2011年學術文章 scienca artikolo 2011年の論文 scientific article published on 20 October 2011 2011 nî lūn-bûn naučni članak artigo científico vetenskaplig artikel teaduslik artikkel artikull shkencor wetenschappelijk artikel научна статия bilimsel makale บทความทางวิทยาศาสตร์ 2011年学术文章 2011年学术文章 2011年學術文章 vědecký článek artykuł naukowy article científic artigo científico videnskabelig artikel мақолаи илмӣ vitenskapelig artikkel articolo scientifico tudományos cikk ২০ অক্টোবর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ מאמר מדעי სამეცნიერო სტატია 2011年學術文章 bài báo khoa học wissenschaftlicher Artikel 2011年学术文章 artikulong pang-agham научная статья article scientific 2011年学术文章 article scientifique наукова стаття, опублікована в жовтні 2011 vitskapeleg artikkel 2011年学术文章 2011年學術文章 2011年學術文章 vedecký článok научни чланак scientific article published on 20 October 2011 научни чланак
p:P577
wds:Q48565555-0238C7B1-04C0-472A-A73D-D533FB08F720
wdt:P577
2011-10-20T00:00:00Z
p:P2888
wds:Q48565555-FAE76ECC-A91A-4499-975D-0803A7708856
wdt:P2888
n7:s11136-011-0037-y
p:P2860
wds:Q48565555-DFEF4376-6318-403F-AF8F-A2518A7F81E2 wds:Q48565555-E6B88289-833B-4382-9764-A3BC9D435FFF wds:Q48565555-F4B71EAC-AF1E-42B6-861D-1B1CC0D598B9 wds:Q48565555-F5267AEE-171C-4A69-9B27-D7A4153141E3 wds:Q48565555-FFE08B92-3EFA-4343-B911-B118F80F8A8E wds:Q48565555-AA5DA38B-EC00-4913-8249-9185D4950CC6 wds:Q48565555-AB391A28-0F70-4B3B-A4C5-91E1535C9CF2 wds:Q48565555-D7ADDF84-A65D-4369-BA08-AE57E19F5084 wds:Q48565555-789656EA-69AF-4790-A40B-6F88178E0014 wds:Q48565555-85A2489D-3E49-4CAB-87F5-6B6ACE361826 wds:Q48565555-96D317D3-3F3D-43FF-BD14-0C1D631DC74A wds:Q48565555-9DEAD6C2-69CA-4875-9533-21DD035B488D wds:Q48565555-04E28576-AB67-4284-91DA-54535DEC1F6E wds:Q48565555-0B30312B-2976-4BA3-8623-F18B10C754CC wds:Q48565555-0E009AF3-1F31-4BDB-8D67-2E440DAF7267 wds:Q48565555-15A2A44C-DFD8-499E-A9B0-D83B597250BB wds:Q48565555-279D8542-E7A3-4900-92A6-DEB7E505640F wds:Q48565555-596BE079-1BCB-4947-A0A5-24DA9B9330BC
wdt:P2860
wd:Q38606701 wd:Q44468648 wd:Q31163374 wd:Q37544416 wd:Q28256780 wd:Q53130212 wd:Q34408145 wd:Q40925956 wd:Q29615701 wd:Q39967702 wd:Q51850542 wd:Q43937776 wd:Q37194965 wd:Q51697431 wd:Q28362081 wd:Q43235131 wd:Q42770059 wd:Q48456328
p:P2093
wds:Q48565555-4F9F4235-2F25-41B7-A7CD-F1C6EBC57172 wds:Q48565555-B645C6EB-ECE0-4A1F-A6D4-2F65D3D63D5E wds:Q48565555-01307641-4F71-4EB1-AB29-C99A27EE2E08
wdt:P2093
Su-Kyoung Ko Hye-Young Kang Eun-ju Kim
rdfs:label
Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients. Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.
skos:prefLabel
Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients. Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.
schema:name
Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients. Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.
p:P1476
wds:Q48565555-806095A3-2E82-468B-B711-DCD83677F4D0
wdt:P1476
Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.
p:P304
wds:Q48565555-E0E33689-372E-407C-9D0A-0B2502F0818F
wdt:P304
1193-1203
p:P31
wds:Q48565555-71B290D7-CFB0-4087-970D-14EDBCDCE819
wdt:P31
wd:Q13442814
p:P921
wds:Q48565555-8A22A2A6-F678-4D5D-8578-0E487AB0B5A5 wds:Q48565555-DBDAF9CC-5F07-4356-817D-4BCB7CD1F2D2
wdt:P921
wd:Q12859063 wd:Q181600
p:P698
wds:Q48565555-65B72D29-2741-45E3-943C-944058870B08
wdtn:P698
n12:22012023
wdt:P698
22012023
p:P1433
wds:Q48565555-F741E6C9-8FA1-4691-8A14-2F417477FEFA
wdt:P1433
wd:Q15749950
p:P433
wds:Q48565555-AA7D15F4-7BF0-48C5-8A44-7AEB74C0365F
p:P478
wds:Q48565555-C3B4B773-75C1-4B55-AECD-40537098CEFC
wdt:P433
7
wdt:P478
21
p:P356
wds:Q48565555-A7B33D6C-E7A3-4059-AD5B-B8BF84085CA3
wdtn:P356
n13:S11136-011-0037-Y
wdt:P356
10.1007/S11136-011-0037-Y